Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
Faron Pharmaceuticals Ltd | Company announcement | June 17, 2026 at 16:30:00 EEST
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:
Faron Pharmaceuticals Ltd
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
x
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights
x
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
x
Other (please specify) iii:
3. Details of person subject to the notification obligationiv
Name
Timo Syrjälä
City and country of registered office (if applicable)
Monaco
4. Full name of shareholder(s) (if different from 3.) v
Name
Acme Investments SPF Sarl
City and country of registered office (if applicable)
Luxembourg
5. Date on which the threshold was crossed or reachedvi:
11.6.2026
6. Date on which issuer notified (DD/MM/YYYY):
16.6.2026
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)
% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached
6.46%
14.712.470
Position of previous notification (if
applicable)
7.77%
15.509.443
8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of shares
ISIN code (if possible)
Number of voting rightsix
% of voting rights
Direct (DTR5.1)
Indirect (DTR5.2.1)
Direct (DTR5.1)
Indirect (DTR5.2.1)
FI4000153309
5.544.672
9.167.798
2.43%
4.02%
SUBTOTAL 8. A
14.712.470
6.46%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument
Expiration datex
Exercise/ Conversion Periodxi
Number of voting rights that may be acquired if the instrument is exercised/converted.
% of voting rights
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument
Expiration datex
Exercise/ Conversion Periodxi
Physical or cash Settlementxii
Number of voting rights
% of voting rights
SUBTOTAL 8.B.2
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv
X
Namexv
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
Timo Syrjälä (Direct)
2.43%
2.43%
Acme Investments SPF Sarl (Indirect)
4.02%
4.02%
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information Faron has changed 11.6.2026 the way the flagging responsibility is defined by calculating also shares registered and issued to Faron and still owned by company itself. However, shares owned by Faron itself cannot be calculated as capable to vote in shareholders meetings. New total number of Faron shares registered 227.881.315.